Ex-Mela chief Gul­fo joins the list of would-be FDA com­mish can­di­dates, col­or-cod­ed drug ap­proval plan in hand

A few weeks ago, Joseph Gul­fo spurred a con­sid­er­able round of chat­ter around a pro­pos­al for a col­or-cod­ed ap­proach to ap­prov­ing new drugs. Es­sen­tial­ly, he wants drug de­vel­op­ers to be able to gain an OK based on a range of fac­tors, in­clud­ing bio­mark­er ev­i­dence of ef­fi­ca­cy.

Now, Gul­fo’s name has been raised — by STAT — as an­oth­er pos­si­ble can­di­date for the top job at the FDA, as the bio­phar­ma in­dus­try anx­ious­ly awaits word on the next com­mis­sion­er and how Pres­i­dent Trump plans to de­liv­er on a promise to speed up new ap­provals even as he bat­ters the in­dus­try with crit­i­cism of its pric­ing strate­gies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER